Gilead Sciences as of June 30, 2026
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 5 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcus Biosciences Incorporated (RCUS) | 58.8 | $969M | 31M | 30.83 | |
| Lakefront Biotherapeutics Spon Adr | 30.3 | $500M | 17M | 29.94 | |
| Assembly Biosciences Com New (ASMB) | 8.3 | $137M | 5.0M | 27.48 | |
| Kyverna Therapeutics (KYTX) | 2.2 | $37M | 4.1M | 8.91 | |
| Xilio Therapeutics | 0.4 | $6.2M | 650k | 9.58 |
